Zoetis (NYSE:ZTS) Shares Unloaded Rep. Rick Larsen

Representative Rick Larsen (D-Washington) recently sold shares of Zoetis Inc. (NYSE:ZTS). In a filing disclosed on October 16th, the Representative disclosed that they had sold between $1,001 and $15,000 in Zoetis stock on October 6th. The trade occurred in the Representative’s “RICHARD R LARSEN IRA” account.

Representative Rick Larsen also recently made the following trade(s):

  • Purchased $1,001 – $15,000 in shares of Walmart (NYSE:WMT) on 10/6/2025.
  • Purchased $1,001 – $15,000 in shares of American Electric Power (NASDAQ:AEP) on 10/6/2025.
  • Sold $1,001 – $15,000 in shares of Colgate-Palmolive (NYSE:CL) on 10/6/2025.
  • Sold $1,001 – $15,000 in shares of Old Dominion Freight Line (NASDAQ:ODFL) on 10/6/2025.
  • Purchased $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 10/6/2025.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $144.15 on Friday. The stock has a market cap of $63.88 billion, a price-to-earnings ratio of 24.81, a P/E/G ratio of 2.30 and a beta of 0.90. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a 1-year low of $139.34 and a 1-year high of $193.49. The stock’s 50-day moving average is $148.73 and its 200 day moving average is $153.76.

Zoetis (NYSE:ZTSGet Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.14. The company had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period last year, the firm posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is currently 34.42%.

Hedge Funds Weigh In On Zoetis

A number of large investors have recently bought and sold shares of the stock. Sound Income Strategies LLC increased its stake in shares of Zoetis by 54.3% during the second quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock valued at $67,000 after buying an additional 152 shares during the period. Canoe Financial LP increased its stake in shares of Zoetis by 859.0% during the second quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock valued at $2,085,000 after buying an additional 11,975 shares during the period. Strs Ohio purchased a new position in shares of Zoetis during the first quarter valued at approximately $22,891,000. Tandem Investment Advisors Inc. increased its stake in shares of Zoetis by 100.3% during the first quarter. Tandem Investment Advisors Inc. now owns 395,626 shares of the company’s stock valued at $65,140,000 after buying an additional 198,089 shares during the period. Finally, Soros Capital Management LLC increased its stake in shares of Zoetis by 32.0% during the first quarter. Soros Capital Management LLC now owns 17,441 shares of the company’s stock valued at $2,872,000 after buying an additional 4,230 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ZTS. Argus reissued a “buy” rating and set a $190.00 price objective on shares of Zoetis in a report on Tuesday, September 9th. Leerink Partners cut Zoetis from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Piper Sandler lifted their price target on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Zoetis has a consensus rating of “Hold” and an average price target of $196.71.

Check Out Our Latest Analysis on Zoetis

About Representative Larsen

Rick Larsen (Democratic Party) is a member of the U.S. House, representing Washington’s 2nd Congressional District. He assumed office on January 3, 2001. His current term ends on January 3, 2027.

Larsen (Democratic Party) is running for re-election to the U.S. House to represent Washington’s 2nd Congressional District. He declared candidacy for the 2026 election.

Since at least 2011, Larsen has been assigned to the Committee on Armed Services and the Committee on Transportation and Infrastructure.

Larsen’s first position as an elected official was in 1998 as a member of the Snohomish County Council.

Larsen earned his bachelor’s degree from Pacific Lutheran University. After earning his master’s degree in public affairs from the University of Minnesota, Larsen worked as the director of public affairs for the Washington State Dental Association and then as an economic development official with the Port of Everett. He went on to serve on the Snohomish County Council before seeking election to the U.S. House.

Zoetis Company Profile

(Get Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Featured Stories

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.